Difference between revisions of "LncRNAWiki:P"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''PACERR'' |ENST00000608917.1 |PACER, PTGS2-AS1 |PTGS2 ant...")
 
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 +
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 +
Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']]
 +
</div>
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
Line 5: Line 8:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''PACERR''
 
|''PACERR''
 
|[[ENST00000608917.1]]
 
|[[ENST00000608917.1]]
−
|PACER, PTGS2-AS1
+
|"PACER, PTGS2-AS1"
 
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
 
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
 +
|inflammation and cancer
 
|-
 
|-
 
|''PANCR''
 
|''PANCR''
Line 15: Line 20:
 
|N/A
 
|N/A
 
|PITX2 adjacent non-coding RNA
 
|PITX2 adjacent non-coding RNA
 +
|_
 
|-
 
|-
 
|''PANDAR''
 
|''PANDAR''
 
|[[lnc-CDKN1A-1:1]]
 
|[[lnc-CDKN1A-1:1]]
−
|P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR
+
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
 
|promoter of CDKN1A antisense DNA damage activated RNA
 
|promoter of CDKN1A antisense DNA damage activated RNA
 +
|breast cancer
 
|-
 
|-
 
|''PAPPA-AS1''
 
|''PAPPA-AS1''
 
|[[PAPPA-AS1]]
 
|[[PAPPA-AS1]]
−
|PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156
+
|"PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156"
 
|PAPPA antisense RNA 1
 
|PAPPA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PAPPA-AS2''
 
|''PAPPA-AS2''
Line 30: Line 38:
 
|AGU1
 
|AGU1
 
|PAPPA antisense RNA 2
 
|PAPPA antisense RNA 2
 +
|stem cell differentiation
 
|-
 
|-
 
|''PART1''
 
|''PART1''
 
|[[ENST00000506884.1]]
 
|[[ENST00000506884.1]]
−
|DKFZP586D0823, NCRNA00206
+
|"DKFZP586D0823, NCRNA00206"
 
|prostate androgen-regulated transcript 1 (non-protein coding)
 
|prostate androgen-regulated transcript 1 (non-protein coding)
 +
|prostate carcinogenesis
 
|-
 
|-
 
|''PARTICL''
 
|''PARTICL''
Line 40: Line 50:
 
|PARTICLE
 
|PARTICLE
 
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
 
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
 +
|_
 
|-
 
|-
 
|''PAUPAR''
 
|''PAUPAR''
Line 45: Line 56:
 
|N/A
 
|N/A
 
|PAX6 upstream antisense RNA
 
|PAX6 upstream antisense RNA
 +
|_
 
|-
 
|-
 
|''PAXIP1-AS1''
 
|''PAXIP1-AS1''
Line 50: Line 62:
 
|N/A
 
|N/A
 
|PAXIP1 antisense RNA 1 (head to head)
 
|PAXIP1 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''PCA3''
 
|''PCA3''
 
|[[ENST00000412654.1]]
 
|[[ENST00000412654.1]]
−
|DD3, NCRNA00019, PCAT3
+
|"DD3, NCRNA00019, PCAT3"
 
|prostate cancer associated 3 (non-protein coding)
 
|prostate cancer associated 3 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT1''
 
|''PCAT1''
 
|[[ENST00000561978.1]]
 
|[[ENST00000561978.1]]
−
|PCAT-1, PCA1
+
|"PCAT-1, PCA1"
 
|prostate cancer associated transcript 1 (non-protein coding)
 
|prostate cancer associated transcript 1 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT14''
 
|''PCAT14''
Line 65: Line 80:
 
|N/A
 
|N/A
 
|prostate cancer associated transcript 14 (non-protein coding)
 
|prostate cancer associated transcript 14 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT18''
 
|''PCAT18''
Line 70: Line 86:
 
|LINC01092
 
|LINC01092
 
|prostate cancer associated transcript 18 (non-protein coding)
 
|prostate cancer associated transcript 18 (non-protein coding)
 +
|metastatic prostate cancer
 
|-
 
|-
 
|''PCAT19''
 
|''PCAT19''
Line 75: Line 92:
 
|LINC01190
 
|LINC01190
 
|prostate cancer associated transcript 19 (non-protein coding)
 
|prostate cancer associated transcript 19 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT29''
 
|''PCAT29''
Line 80: Line 98:
 
|N/A
 
|N/A
 
|prostate cancer associated transcript 29 (non-protein coding)
 
|prostate cancer associated transcript 29 (non-protein coding)
 +
|prostate cancer
 
|-
 
|-
 
|''PCAT4''
 
|''PCAT4''
 
|[[ENST00000504263.1]]
 
|[[ENST00000504263.1]]
−
|GDEP, PCAN1, PCA4
+
|"GDEP, PCAN1, PCA4"
 
|prostate cancer associated transcript 4 (non-protein coding)
 
|prostate cancer associated transcript 4 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT5''
 
|''PCAT5''
Line 90: Line 110:
 
|TPCAT-10-36067
 
|TPCAT-10-36067
 
|prostate cancer associated transcript 5 (non-protein coding)
 
|prostate cancer associated transcript 5 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCAT6''
 
|''PCAT6''
 
|[[PCAT6]]
 
|[[PCAT6]]
 +
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
 
|N/A
 
|N/A
−
|Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288
+
|prostate cancer
 
|-
 
|-
 
|''PCAT7''
 
|''PCAT7''
−
|[[PCAT7]]
+
|[[ENST00000452148.2]]
 
|PCAN-R2
 
|PCAN-R2
 
|prostate cancer associated transcript 7 (non-protein coding)
 
|prostate cancer associated transcript 7 (non-protein coding)
 +
|Prostate Cancer
 
|-
 
|-
 
|''PCBP2-OT1''
 
|''PCBP2-OT1''
Line 105: Line 128:
 
|TUC338
 
|TUC338
 
|PCBP2 overlapping transcript 1
 
|PCBP2 overlapping transcript 1
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''PCBP3-OT1''
 
|''PCBP3-OT1''
Line 110: Line 134:
 
|FLJ44028
 
|FLJ44028
 
|PCBP3 overlapping transcript 1
 
|PCBP3 overlapping transcript 1
 +
|DNA damage
 
|-
 
|-
 
|''PCF11-AS1''
 
|''PCF11-AS1''
Line 115: Line 140:
 
|ENST00000602322.1
 
|ENST00000602322.1
 
|PCF11 anstisense RNA 1
 
|PCF11 anstisense RNA 1
 +
|_
 
|-
 
|-
 
|''PCGEM1''
 
|''PCGEM1''
Line 120: Line 146:
 
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
 
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
 
|Prostate-specific transcript 1
 
|Prostate-specific transcript 1
 +
|prostate cancer
 
|-
 
|-
 
|''PCNA-AS1''
 
|''PCNA-AS1''
Line 125: Line 152:
 
|N/A
 
|N/A
 
|PCNA antisense RNA 1
 
|PCNA antisense RNA 1
 +
|tumor
 
|-
 
|-
 
|''PEG13''
 
|''PEG13''
Line 130: Line 158:
 
|N/A
 
|N/A
 
|paternally expressed 13
 
|paternally expressed 13
 +
|_
 
|-
 
|-
 
|''PEG3-AS1''
 
|''PEG3-AS1''
 
|[[PEG3-AS1]]
 
|[[PEG3-AS1]]
−
|APEG3, NCRNA00155
+
|"APEG3, NCRNA00155"
 
|PEG3 antisense RNA 1
 
|PEG3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PICSAR''
 
|''PICSAR''
 
|[[PICSAR]]
 
|[[PICSAR]]
−
|PRED74, NLC1-C
+
|"PRED74, NLC1-C"
 
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
 
|P38 inhibited cutaneous squamous cell carcinoma associated lincRNA
 +
|Cutaneous Squamous Cell Carcinoma
 
|-
 
|-
 
|''PINK1-AS''
 
|''PINK1-AS''
 
|[[PINK1-AS]]
 
|[[PINK1-AS]]
−
|FLJ00387, PINK1AS, naPINK1
+
|"FLJ00387, PINK1AS, naPINK1"
 
|PINK1 antisense RNA
 
|PINK1 antisense RNA
 +
|_
 
|-
 
|-
 
|''PISRT1''
 
|''PISRT1''
Line 150: Line 182:
 
|NCRNA00195
 
|NCRNA00195
 
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
 
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA)
 +
|blepharophimosis syndrome
 
|-
 
|-
 
|''PR antisense transcripts''
 
|''PR antisense transcripts''
Line 155: Line 188:
 
|N/A
 
|N/A
 
|N/A
 
|N/A
 +
|_
 
|-
 
|-
 
|''PRINS''
 
|''PRINS''
Line 160: Line 194:
 
|ENSG00000238115
 
|ENSG00000238115
 
|Psoriasis susceptibility-related RNA Gene Induced by Stress
 
|Psoriasis susceptibility-related RNA Gene Induced by Stress
 +
|psoriasis
 
|-
 
|-
 
|''PRKCQ-AS1''
 
|''PRKCQ-AS1''
Line 165: Line 200:
 
|ENST00000414894.1
 
|ENST00000414894.1
 
|PRKCQ antisense RNA 1
 
|PRKCQ antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PRNCR1''
 
|''PRNCR1''
Line 170: Line 206:
 
|N/A
 
|N/A
 
|prostate cancer associated non-coding RNA 1
 
|prostate cancer associated non-coding RNA 1
 +
|Prostate Cancer
 
|-
 
|-
 
|''PRR7-AS1''
 
|''PRR7-AS1''
Line 175: Line 212:
 
|N/A
 
|N/A
 
|PRR7 antisense RNA 1
 
|PRR7 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PSMA3-AS1''
 
|''PSMA3-AS1''
Line 180: Line 218:
 
|FLJ31306
 
|FLJ31306
 
|PSMA3 antisense RNA 1
 
|PSMA3 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PSMD5-AS1''
 
|''PSMD5-AS1''
Line 185: Line 224:
 
|N/A
 
|N/A
 
|PSMD5 antisense RNA 1 (head to head)
 
|PSMD5 antisense RNA 1 (head to head)
 +
|_
 
|-
 
|-
 
|''PTCSC1''
 
|''PTCSC1''
 
|[[NONHSAT129210]]
 
|[[NONHSAT129210]]
−
|AK023948, NCRNA00197
+
|AK023948
 
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
 +
|thyroid carcinoma
 
|-
 
|-
 
|''PTCSC2''
 
|''PTCSC2''
Line 195: Line 236:
 
|N/A
 
|N/A
 
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
 +
|papillary thyroid carcinoma
 
|-
 
|-
 
|''PTCSC3''
 
|''PTCSC3''
Line 200: Line 242:
 
|N/A
 
|N/A
 
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
 
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
 +
|psoriasis
 
|-
 
|-
 
|''PTENP1''
 
|''PTENP1''
 
|[[NONHSAT130775]]
 
|[[NONHSAT130775]]
−
|PTENpg1, PTEN2, ENSG00000237984
+
|"PTENpg1, PTEN2, ENSG00000237984"
 
|PTEN Pseudogene 1
 
|PTEN Pseudogene 1
 +
|prostate cancer
 
|-
 
|-
 
|''PTENP1-AS''
 
|''PTENP1-AS''
Line 210: Line 254:
 
|PTENpg1-asRNA
 
|PTENpg1-asRNA
 
|PTENP1 antisense RNA
 
|PTENP1 antisense RNA
 +
|_
 
|-
 
|-
 
|''PTPRJ-AS1''
 
|''PTPRJ-AS1''
Line 215: Line 260:
 
|N/A
 
|N/A
 
|PTPRJ antisense RNA 1
 
|PTPRJ antisense RNA 1
 +
|_
 
|-
 
|-
 
|''PVT1''
 
|''PVT1''
 
|[[ENST00000513868.2]]
 
|[[ENST00000513868.2]]
−
|NCRNA00079, LINC00079, onco-lncRNA-100
+
|"NCRNA00079, LINC00079, onco-lncRNA-100"
 
|Pvt1 oncogene (non-protein coding)
 
|Pvt1 oncogene (non-protein coding)
 +
|breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer
 
|-
 
|-
 
|''PWAR1''
 
|''PWAR1''
 
|[[PWAR1]]
 
|[[PWAR1]]
−
|PAR1, PAR-1
+
|"PAR1, PAR-1"
 
|Prader Willi/Angelman region RNA 1
 
|Prader Willi/Angelman region RNA 1
 +
|_
 
|-
 
|-
 
|''PWAR4''
 
|''PWAR4''
 
|[[PWAR4]]
 
|[[PWAR4]]
−
|PAR4, PAR-4
+
|"PAR4, PAR-4"
 
|Prader Willi/Angelman region RNA 4
 
|Prader Willi/Angelman region RNA 4
 +
|_
 
|-
 
|-
 
|''PWAR5''
 
|''PWAR5''
 
|[[PWAR5]]
 
|[[PWAR5]]
−
|PAR5, PAR-5
+
|"PAR5, PAR-5"
 
|Prader Willi/Angelman region RNA 5
 
|Prader Willi/Angelman region RNA 5
 +
|_
 
|-
 
|-
 
|''PWARSN''
 
|''PWARSN''
 
|[[PWARSN]]
 
|[[PWARSN]]
−
|PAR-SN, PARSN
+
|"PAR-SN, PARSN"
−
|Prader Willi/Angelman region RNA, SNRPN neighbor
+
|"Prader Willi/Angelman region RNA, SNRPN neighbor"
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''PWRN1''
 
|''PWRN1''
Line 245: Line 296:
 
|NCRNA00198
 
|NCRNA00198
 
|Prader-Willi region non-protein coding RNA 1
 
|Prader-Willi region non-protein coding RNA 1
 +
|Prader-Willi syndrome
 
|-
 
|-
 
|''PWRN2''
 
|''PWRN2''
Line 250: Line 302:
 
|NCRNA00199
 
|NCRNA00199
 
|Prader-Willi region non-protein coding RNA 2
 
|Prader-Willi region non-protein coding RNA 2
 +
|Prader-Willi syndrome
 +
|-
 +
|-
 +
|''P4HA3-AS1''
 +
|[[P4HA3-AS1]]
 +
|N/A
 +
|P4HA3 antisense RNA 1
 +
|_
 +
|-
 +
|''PCSK6-AS1''
 +
|[[PCSK6-AS1]]
 +
|N/A
 +
|PCSK6 antisense RNA 1
 +
|_
 +
|-
 +
|''PGR-AS1''
 +
|[[PGR-AS1]]
 +
|AT1, AT2, AT3
 +
|PGR antisense RNA 1
 +
|_
 +
|-
 +
|''POC1B-AS1''
 +
|[[POC1B-AS1]]
 +
|RP11-734K2
 +
|4
 +
|POC1B antisense RNA 1
 +
|-
 +
|''PPP1R12A-AS1''
 +
|[[PPP1R12A-AS1]]
 +
|R12A-AS1
 +
|PPP1R12A antisense RNA 1
 +
|_
 +
|-
 +
|''PRNT''
 +
|[[PRNT]]
 +
|M8
 +
|prion locus lncRNA, testis expressed
 +
|_
 
|}
 
|}

Latest revision as of 12:40, 29 June 2017

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z BACK

Name Transcript ID Alias Description Disease
PACERR ENST00000608917.1 "PACER, PTGS2-AS1" PTGS2 antisense NFKB1 complex-mediated expression regulator RNA inflammation and cancer
PANCR PANCR N/A PITX2 adjacent non-coding RNA _
PANDAR lnc-CDKN1A-1:1 "P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR" promoter of CDKN1A antisense DNA damage activated RNA breast cancer
PAPPA-AS1 PAPPA-AS1 "PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156" PAPPA antisense RNA 1 _
PAPPA-AS2 PAPPA-AS2 AGU1 PAPPA antisense RNA 2 stem cell differentiation
PART1 ENST00000506884.1 "DKFZP586D0823, NCRNA00206" prostate androgen-regulated transcript 1 (non-protein coding) prostate carcinogenesis
PARTICL PARTICL PARTICLE promoter of MAT2A antisense radiation-induced circulating long non-coding RNA _
PAUPAR NONHSAT018635 N/A PAX6 upstream antisense RNA _
PAXIP1-AS1 PAXIP1-AS1 N/A PAXIP1 antisense RNA 1 (head to head) _
PCA3 ENST00000412654.1 "DD3, NCRNA00019, PCAT3" prostate cancer associated 3 (non-protein coding) Prostate Cancer
PCAT1 ENST00000561978.1 "PCAT-1, PCA1" prostate cancer associated transcript 1 (non-protein coding) Prostate Cancer
PCAT14 PCAT14 N/A prostate cancer associated transcript 14 (non-protein coding) prostate cancer
PCAT18 PCAT18 LINC01092 prostate cancer associated transcript 18 (non-protein coding) metastatic prostate cancer
PCAT19 PCAT19 LINC01190 prostate cancer associated transcript 19 (non-protein coding) prostate cancer
PCAT29 PCAT29 N/A prostate cancer associated transcript 29 (non-protein coding) prostate cancer
PCAT4 ENST00000504263.1 "GDEP, PCAN1, PCA4" prostate cancer associated transcript 4 (non-protein coding) Prostate Cancer
PCAT5 PCAT5 TPCAT-10-36067 prostate cancer associated transcript 5 (non-protein coding) Prostate Cancer
PCAT6 PCAT6 "Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288" N/A prostate cancer
PCAT7 ENST00000452148.2 PCAN-R2 prostate cancer associated transcript 7 (non-protein coding) Prostate Cancer
PCBP2-OT1 PCBP2-OT1 TUC338 PCBP2 overlapping transcript 1 hepatocellular carcinoma
PCBP3-OT1 PCBP3-OT1 FLJ44028 PCBP3 overlapping transcript 1 DNA damage
PCF11-AS1 PCF11-AS1 ENST00000602322.1 PCF11 anstisense RNA 1 _
PCGEM1 NONHSAT076153 ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA Prostate-specific transcript 1 prostate cancer
PCNA-AS1 PCNA-AS1 N/A PCNA antisense RNA 1 tumor
PEG13 PEG13 N/A paternally expressed 13 _
PEG3-AS1 PEG3-AS1 "APEG3, NCRNA00155" PEG3 antisense RNA 1 _
PICSAR PICSAR "PRED74, NLC1-C" P38 inhibited cutaneous squamous cell carcinoma associated lincRNA Cutaneous Squamous Cell Carcinoma
PINK1-AS PINK1-AS "FLJ00387, PINK1AS, naPINK1" PINK1 antisense RNA _
PISRT1 PISRT1 NCRNA00195 polled intersex syndrome regulated transcript 1 (non-protein coding RNA) blepharophimosis syndrome
PR antisense transcripts NONHSAT023851 N/A N/A _
PRINS NONHSAT011777 ENSG00000238115 Psoriasis susceptibility-related RNA Gene Induced by Stress psoriasis
PRKCQ-AS1 PRKCQ-AS1 ENST00000414894.1 PRKCQ antisense RNA 1 _
PRNCR1 NONHSAT129019 N/A prostate cancer associated non-coding RNA 1 Prostate Cancer
PRR7-AS1 PRR7-AS1 N/A PRR7 antisense RNA 1 _
PSMA3-AS1 PSMA3-AS1 FLJ31306 PSMA3 antisense RNA 1 _
PSMD5-AS1 PSMD5-AS1 N/A PSMD5 antisense RNA 1 (head to head) _
PTCSC1 NONHSAT129210 AK023948 papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) thyroid carcinoma
PTCSC2 ENST00000430058.1 N/A papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) papillary thyroid carcinoma
PTCSC3 ENST00000556013.2 N/A papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) psoriasis
PTENP1 NONHSAT130775 "PTENpg1, PTEN2, ENSG00000237984" PTEN Pseudogene 1 prostate cancer
PTENP1-AS PTENP1-AS PTENpg1-asRNA PTENP1 antisense RNA _
PTPRJ-AS1 PTPRJ-AS1 N/A PTPRJ antisense RNA 1 _
PVT1 ENST00000513868.2 "NCRNA00079, LINC00079, onco-lncRNA-100" Pvt1 oncogene (non-protein coding) breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer
PWAR1 PWAR1 "PAR1, PAR-1" Prader Willi/Angelman region RNA 1 _
PWAR4 PWAR4 "PAR4, PAR-4" Prader Willi/Ang